A bipartisan group of lawmakers led by Rep. Greg Murphy (R-NC) reintroduced the Ensuring Pathways to Innovative Cures (EPIC) Act to counter what they call a “pill penalty” in the Inflation Reduction Act (IRA), which they argue discourages research into small molecule drugs. The move follows a meeting last week between the brand-name drug lobby and President Donald Trump, where the group pledged to boost biopharmaceutical innovation and lower drug costs. The Pharmaceutical Research and Manufacturers of America (PhRMA) have...